The Global Cardiovascular Diagnostics Industry is on a trajectory of unprecedented growth, forecasted to surge from US$ 5.6 Billion in 2022 to a staggering US$ 9.7 Billion by the conclusion of 2033. This remarkable expansion, projected at a robust Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period (2023 to 2033), underscores the …